"A human doctor saves the individual, a veterinarian saves mankind"
- Louis Pasteur
4876 – the enzyme-linked immunosorbent assay (ELISA) for the quantitative determination of antibodies against the avian infectious laryngotracheitis (ILT) virus
Avian infectious laryngotracheitis (ILT) is an avian respiratory disease caused by a herpesvirus, with widespread distribution, which affects poultry and wild birds. According to the OIE Manual, the laboratory diagnosis of this disease is based on proving the presence of the virus or viral antigens or on proving the presence of the specific antibodies in the bird serum. The etiologic agent only affects birds and has no significance in human pathology.
Palliative treatments in the outbreaks of disease, with repeated sets of antibiotics and vitamins, primarily aim at reducing mortality losses due to secondary infections with other germs.
Disease control is accomplished by appropriate vaccinations, carried out in the 6th and 14th week, respectively; their effectiveness can be serologically tested by way of ELISA.
The serological exam seeks to detect the specific antibodies of the avian infectious laryngotracheitis virus by using ELISA immunoenzymatic techniques that meet the requirements of specificity and sensitivity.
gallinaceous bird blood serum
2 business days
quantitative determination of the antibodies against the avian infectious laryngotracheitis virus from gallinaceous bird sera by way of the enzyme-linked immunosorbent ELISA assay, the indirect version